GoldenGolden
Bioeconomy Capital

Bioeconomy Capital

Bioeconomy Capital is a biotechnology investment firm. The primary focus of Bioeconomy Captial is the industrialization of early stage biotechnology companies operating within the bioeconomy making products such as materials, chemicals, and enzymes.

All edits

Edits on 21 Apr, 2021
Golden AI
Golden AI edited on 21 Apr, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Lumen Bioscience
Edits on 14 Apr, 2021
Golden AI
Golden AI edited on 14 Apr, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Edits on 29 Mar, 2021
Golden AI
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Golden AI
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 29 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Edits on 7 Oct, 2020
Daniel Frumkin"added to article to surpass 1000 characters"
Daniel Frumkin edited on 7 Oct, 2020
Edits made to:
Article (+334 characters)
Article

Bioeconomy Capital is interested in accelerating the strategic analysis of building blueprints and releasing technological capabilities. They look to support synthetic biology and related fields through investments. The company looks to segregate their investments into subsectors including, biologics, crops, and industrial products.

Edits on 24 Sep, 2019
Mevludin Mešanović"Approved suggestion #668785"
Mevludin Mešanović approved a suggestion from Golden's AI on 24 Sep, 2019
Edits made to:
Infobox (+1 properties)
Edits on 24 Sep, 2019
Neelam Jhaveri
Neelam Jhaveri edited on 24 Sep, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Neelam Jhaveri
Neelam Jhaveri edited on 24 Sep, 2019
Edits made to:
Infobox (+1 properties)
Edits on 4 Jun, 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 4 Jun, 2019
Edits made to:
Article (+10/-10 characters)
Article

On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and BellwetherBellwether Bio.

Edits on 29 May, 2019
Golden AI
Golden AI edited on 29 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 21 Jan, 2019
Golden AI"Changed markets to industries"
Golden AI edited on 21 Jan, 2019
Edits made to:
Infobox (+4/-4 properties)
Infobox
Market
Edits on 10 Jan, 2019
Golden AI
Golden AI edited on 10 Jan, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 18 Dec, 2018
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 18 Dec, 2018
Edits made to:
Article (+8/-8 characters)
Article

On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — ZymergenZymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.

Edits on 12 Dec, 2018
Golden AI"Import data"
Golden AI edited on 12 Dec, 2018
Edits made to:
Infobox (+2 properties)
People (+2 rows) (+4 cells) (+35 characters)
People

Name
Role
Related Golden topics

Tim Fell

Employee

Tim Gardner

Employee

Infobox
Edits on 19 Jul, 2018
Golden AI"Update locations in infobox"
Golden AI edited on 19 Jul, 2018
Infobox
Edits on 18 Jul, 2018
Jude Gomila
Jude Gomila edited on 18 Jul, 2018
Edits made to:
Article (+6/-6 characters)
Article

On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, ArzedaArzeda, and Bellwether Bio.

Infobox
Jude Gomila
Jude Gomila edited on 18 Jul, 2018
Edits made to:
Article (+8/-8 characters)
Article

On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, SynthaceSynthace, Arzeda, and Bellwether Bio.

Infobox
Edits on 16 Jul, 2018
Golden AI"Update markets in infobox"
Golden AI edited on 16 Jul, 2018
Edits on 12 Jul, 2018
Carla Faraguna
Carla Faraguna edited on 12 Jul, 2018
Edits made to:
Article (+6/-6 characters)
Article

On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, RiffynRiffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.

Infobox
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.